Questionnaire survey for perspectives of patients and doctors on diagnosis and treatment in Parkinson's disease; PD voice study

Questionnaire survey for perspectives of patients and doctors on diagnosis and treatment in Parkinson's disease; PD voice study - PD voice study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000035769

Enrollment

700

Registered

2019-02-10

Start date

2019-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: <Patients and their families> Subjects must satisfy all of the following criteria. 1)The patient or his/her family had a diagnosis of PD and is visiting hospital. 2)Among 4 major symptoms of PD (postural instability,tremor,rigidity,bradykinesia),the patient (patient or his/her family) has 2 symptoms including bradykinesia. 3)In case of patient's family, he or she can live with the patient and respond on behalf of the patient. <Doctors> Subjects must satisfy one of the following criteria according to affiliated department. 1)Neurologists who examined 25 PD patients or more during the last 6 months. 2)Neurosurgeons who examined 5 PD patients or more during the last 6 months. 3)Doctors other than 1) and 2) who examined 10 PD patients or more during the last 6 months.

Exclusion criteria

Exclusion criteria: no matching the key inclusion criteria

Design outcomes

Primary

Measure	Time frame
<Survey of patients and their families> 1) Disease-related information2) Satisfaction with treatment, satisfaction with consultation 3) Factors inhibiting early diagnosis/early treatment4) Understanding of the disease5) Understanding of the symptoms 6) Awareness of the treatment <Survey of doctors> 1) Disease-related information2) Satisfaction with treatment, satisfaction with consultation 3) Factors inhibiting early diagnosis and early treatment4) Explanation of the disease5) Understanding of the symptoms6) Awareness of the treatment	—

Measure

Time frame

<Survey of patients and their families> 1) Disease-related information2) Satisfaction with treatment, satisfaction with consultation 3) Factors inhibiting early diagnosis/early treatment4) Understanding of the disease5) Understanding of the symptoms 6) Awareness of the treatment <Survey of doctors> 1) Disease-related information2) Satisfaction with treatment, satisfaction with consultation 3) Factors inhibiting early diagnosis and early treatment4) Explanation of the disease5) Understanding of the symptoms6) Awareness of the treatment

—

Countries

Japan

Contacts

Public ContactTakayuki Ishida

Takeda Pharmaceutical Company Limited Japan Medical Affairs

takayuki.ishida@takeda.com03-3278-1256

Outcome results